Relation of lysosomal fragility in CLL lymphocytes to PHA reactivity.
D000135:Acid Phosphatase / Q000378:metabolism; D005966:Glucuronidase / Q000378:metabolism; D006801:Humans; D037102:Lectins / Q000494:pharmacology*; D007945:Leukemia, Lymphoid / Q000276:immunology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008247:Lysosomes / Q000187:drug effects* / Q000201:enzymology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D037102:Lectins; D008244:Lysophosphatidylcholines; D014316:Tritium; D000135:Acid Phosphatase; D005966:Glucuronidase; D013936:Thymidine